Mindy K. Graham

735 total citations
18 papers, 352 citations indexed

About

Mindy K. Graham is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Mindy K. Graham has authored 18 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Physiology and 4 papers in Oncology. Recurrent topics in Mindy K. Graham's work include Telomeres, Telomerase, and Senescence (9 papers), DNA Repair Mechanisms (3 papers) and Cancer Research and Treatments (2 papers). Mindy K. Graham is often cited by papers focused on Telomeres, Telomerase, and Senescence (9 papers), DNA Repair Mechanisms (3 papers) and Cancer Research and Treatments (2 papers). Mindy K. Graham collaborates with scholars based in United States, France and Germany. Mindy K. Graham's co-authors include Alan K. Meeker, Christopher M. Heaphy, Paul S. Miller, Terry R. Brown, David Esopi, Angelo M. De Marzo, Jacqueline A. Brosnan‐Cashman, Anne Marie Lennon, Christopher L. Wolfgang and Srinivasan Yegnasubramanian and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Nature Biotechnology.

In The Last Decade

Mindy K. Graham

17 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mindy K. Graham United States 11 203 122 98 59 54 18 352
Julia W. Grimstead United Kingdom 12 256 1.3× 246 2.0× 58 0.6× 18 0.3× 26 0.5× 20 420
Katja Helenius Finland 5 276 1.4× 38 0.3× 119 1.2× 48 0.8× 89 1.6× 6 383
Denise Levitan United States 8 331 1.6× 44 0.4× 86 0.9× 19 0.3× 83 1.5× 18 546
Sook Kyung South Korea 8 105 0.5× 34 0.3× 104 1.1× 65 1.1× 50 0.9× 29 229
May Elbanna United States 7 136 0.7× 39 0.3× 72 0.7× 85 1.4× 63 1.2× 16 252
Emanuela Chimienti Italy 8 63 0.3× 27 0.2× 116 1.2× 35 0.6× 28 0.5× 13 272
Sayaka Ueno Japan 10 85 0.4× 19 0.2× 85 0.9× 62 1.1× 39 0.7× 29 309
Yuemei Yang China 12 167 0.8× 24 0.2× 42 0.4× 40 0.7× 115 2.1× 24 303
Pierre‐Emmanuel Stoebner France 10 126 0.6× 20 0.2× 108 1.1× 24 0.4× 48 0.9× 27 263
Jennifer Dine United States 7 114 0.6× 12 0.1× 162 1.7× 41 0.7× 39 0.7× 14 309

Countries citing papers authored by Mindy K. Graham

Since Specialization
Citations

This map shows the geographic impact of Mindy K. Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mindy K. Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mindy K. Graham more than expected).

Fields of papers citing papers by Mindy K. Graham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mindy K. Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mindy K. Graham. The network helps show where Mindy K. Graham may publish in the future.

Co-authorship network of co-authors of Mindy K. Graham

This figure shows the co-authorship network connecting the top 25 collaborators of Mindy K. Graham. A scholar is included among the top collaborators of Mindy K. Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mindy K. Graham. Mindy K. Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Graham, Mindy K., Beisi Xu, Christine Davis, et al.. (2024). The TERT Promoter is Polycomb-Repressed in Neuroblastoma Cells with Long Telomeres. Cancer Research Communications. 4(6). 1533–1547. 3 indexed citations
3.
Sharma, Abhishek, Katrin Neumann, Anthony Rizzo, et al.. (2023). DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks. Nucleic Acids Research. 52(3). 1136–1155. 7 indexed citations
4.
Brennen, W. Nathaniel, Mindy K. Graham, Tamara L. Lotan, et al.. (2023). Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer. Nature Reviews Urology. 21(5). 258–273. 11 indexed citations
5.
Graham, Mindy K., Rulin Wang, Ajay Vaghasia, et al.. (2022). Single‐cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate. The Prostate. 83(3). 286–303. 11 indexed citations
6.
Heaphy, Christopher M., Michael C. Haffner, Mindy K. Graham, et al.. (2020). Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate. Human Pathology. 101. 70–79. 4 indexed citations
7.
Esopi, David, Mindy K. Graham, Jacqueline A. Brosnan‐Cashman, et al.. (2020). Pervasive promoter hypermethylation of silenced TERT alleles in human cancers. Cellular Oncology. 43(5). 847–861. 14 indexed citations
8.
Graham, Mindy K., Jacqueline A. Brosnan‐Cashman, Anthony Rizzo, et al.. (2019). Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells. Molecular Cancer Research. 17(12). 2480–2491. 22 indexed citations
9.
Rodríguez, Fausto J., Mindy K. Graham, Jacqueline A. Brosnan‐Cashman, et al.. (2019). Telomere alterations in neurofibromatosis type 1-associated solid tumors. Acta Neuropathologica Communications. 7(1). 139–139. 11 indexed citations
10.
Brosnan‐Cashman, Jacqueline A., Ming Yuan, Mindy K. Graham, et al.. (2018). ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner. PLoS ONE. 13(9). e0204159–e0204159. 43 indexed citations
11.
Graham, Mindy K., Ben Ho Park, & Nicolas Wyhs. (2018). Personalized postdoctoral fellowship care. Nature Biotechnology. 36(9). 900–902. 2 indexed citations
12.
VandenBussche, Christopher J., Derek B. Allison, Mindy K. Graham, et al.. (2017). Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors. Cancer Cytopathology. 125(7). 544–551. 44 indexed citations
13.
Becker, Aline Paixão, Erica H. Bell, Jessica L. Fleming, et al.. (2017). Comprehensive assessment of ATRX mutation, protein expression, and alternative lengthening of telomeres (ALT) phenotype in grade II and III gliomas.. Journal of Clinical Oncology. 35(15_suppl). 2064–2064. 2 indexed citations
14.
Graham, Mindy K. & Alan K. Meeker. (2017). Telomeres and telomerase in prostate cancer development and therapy. Nature Reviews Urology. 14(10). 607–619. 86 indexed citations
15.
Valle, Javier Baena-Del, Qizhi Zheng, David Esopi, et al.. (2017). MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer. The Journal of Pathology. 244(1). 11–24. 46 indexed citations
16.
Graham, Mindy K., et al.. (2016). Low p16INK4aExpression in Early Passage Human Prostate Basal Epithelial Cells Enables Immortalization by Telomerase Expression Alone. The Prostate. 77(4). 374–384. 13 indexed citations
17.
Graham, Mindy K., Terry R. Brown, & Paul S. Miller. (2015). Targeting the Human Androgen Receptor Gene with Platinated Triplex-Forming Oligonucleotides. Biochemistry. 54(13). 2270–2282. 24 indexed citations
18.
Graham, Mindy K. & Paul S. Miller. (2012). Inhibition of transcription by platinated triplex-forming oligonucleotides. JBIC Journal of Biological Inorganic Chemistry. 17(8). 1197–1208. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026